ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc. (ONCY) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: March 12, 2026 , by Kelly Jared .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Kelly Jared | Chief Executive Officer | Buy | 5,050 | $0.96 | $4.8K | 114,050 | |
| Parsons James T. | Director | Buy | 10,000 | $1.03 | $10.3K | 41,849 | |
| Seizinger Bernd R. | Director | Buy | 40,000 | $0.85 | $33.9K | 566,991 | |
| Andrews Patricia S | Director | Buy | 35,400 | $0.86 | $30.3K | 78,128 | |
| Pisano Wayne | Director | Buy | 30,000 | $0.84 | $25.3K | 492,414 | |
| Kelly Jared | Chief Executive Officer | Buy | 29,500 | $0.84 | $24.8K | 109,000 | |
| Brown Deborah Margaret | Director | Buy | 25,000 | $0.85 | $21.2K | 109,851 | |
| Look Kirk | Chief Financial Officer | Buy | 12,000 | $0.84 | $10.1K | 287,515 | |
| Heineman Thomas Charles | Chief Medical Officer | Buy | 12,132 | $0.83 | $10.0K | 282,818 | |
| Hagerman Allison | VP, Product Development | Buy | 10,000 | $0.83 | $8.3K | 115,059 | |
| Seizinger Bernd R. | Director | Buy | 60,000 | $0.83 | $49.6K | 526,991 | |
| Aromando Andrew | Chief Business Officer | Buy | 29,600 | $0.86 | $25.4K | 55,100 | |
| Kelly Jared | Chief Executive Officer | Buy | 5,600 | $0.84 | $4.7K | 79,500 | |
| Seizinger Bernd R. | Director | Buy | 100,000 | $1.04 | $103.8K | 466,991 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.